Exondys 51: First Drug to Treat DMD Gets Approval from US FDA
The US regulatory authority on 18th Sep approved Exondys 51 (eteplirsen), Sarepta Therapeutics’ initial drug to treat individuals with Duchenne
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine